SOURCE: Patheon


April 16, 2015 16:00 ET

Patheon Scientist to Give Keynote Address at Lyophilisation USA Conference

DURHAM, NC--(Marketwired - April 16, 2015) - A top scientific expert at Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, will be the keynote speaker at this year's Lyophilisation USA Conference, Wednesday, April 29, through Thursday, April 30, at the Renaissance Woodbridge Hotel in Iselin, N.J.

Ronald Pate, lyophilization development scientist, will present, "Cycle Development Basic Concepts and Optimizing the Process," on Wednesday, April 29, at 9:10 a.m. Pate, who has 15 years of freeze drying and lyophilization experience, will highlight how to scale-up and optimize development to enable shorter cycle times and cost efficient processing of lyophilized formulations, while ensuring consistency within batches. He will discuss the science of lyophilization as it relates to freeze drying process control, and the rationale for recommending lyophilzation to clients.

"I look forward to speaking about lyophilization cycle development," said Pate. "Lyophilization is often the only way to make a drug substance viable for large scale commercial production. Implicit with the responsibility of developing a safe, effective and efficient lyophilization process, is the reward of knowing that millions of lives will be improved by the quality of your work."

For more information and to request a copy of Pate's presentation, visit

About Patheon
Patheon, a business unit of DPx Holdings B.V., delivers a combination of unrivaled quality, reliability and compliance, with a reputation for scientific and technical excellence to customers in the pharmaceutical and biopharma sector. A leading global provider with more than 8,000 employees worldwide, Patheon has a comprehensive set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. For more information, visit

Contact Information